Innate Pharma S.A. Made Big Gain

Innate Pharma S.A. (IPHA:NASDAQ) jumped higher at $3.02, a gain of 96.1%. On Fri, Dec 13, 2024, IPHA:NASDAQ hit a New 2-Week High of $3.02. The stock appeared on our News Catalysts scanner on Thu, Dec 12, 2024 at 03:12 AM in the 'MISCELLANEOUS' category. From Fri, Nov 29, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days

About Innate Pharma S.A. (IPHA:NASDAQ)

Innate Pharma SA is a clinical-stage biotechnology company. The company is engaged in discovering and developing first-in-class therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. It specializes in immuno-oncology, a new therapeutic field that is changing cancer treatment by mobilizing the power of the body's immune system to recognize and kill cancer cells. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies.